Uncategorized Archives - Oncology Central Oncology Central

New research from @CR_UK published in @NatureMedicine investigates how blood samples from patients can be analyzed in order to understand the growth, evolution and potential signs of treatment resistance of lung cancer.
https://t.co/hUaii293Uz

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Protected: Gene fusions in cancer: understanding the basics of oncogenic fusion detection strategies

Protected: Panel discussion: the future of oncology

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

In Focus: lung cancer

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Researchers identify a novel way to target chemo-resistance leukaemia cells – an interview with Peter Stern

Thank you for requesting our ‘Sponsorship opportunities’ pack

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

Login

Uncategorized

Must read